Six independent proteomics studies show that CSF levels of clusterin are significantly increased in AD patients (see meta-analysis in Pedrero-Prieto et al., 2020); plasma levels also rise in ALS (Xu et al., 2018). The gene discussed is CLU; the disease is Alzheimer disease.